TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/2/23 17:03 | 5/31/23 | TERN | Terns Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sundaram Senthil Vel | CA | DO | CEO | P | 3 | 1.41 | 0 | 2 | 28 | 10 | D | ||||||||||||||
2/3/23 18:00 | 11/30/22 | TERN | Terns Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sundaram Senthil Vel | CA | DO | CEO | P.d | 0 | 1.41 | 0 | 0 | 0 | 8 | D | ||||||||||||||
6/8/22 21:27 | 5/31/22 | TERN | Terns Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sundaram Senthil Vel | CA | DO | CEO | P | 11 | 1.47 | 0 | 8 | New | 8 | D | ||||||||||||||
4/3/19 21:02 | 4/1/19 | NITE | Nightstar Therapeutics Plc | X0 | Health | BioPrd | Biological Products, (No Diag | Sundaram Senthil Vel | MA | O | CFO | S | -10 | 25.31 | 0 | 0 | 0 | 127 | D | ||||||||||||||
1/9/19 21:13 | 1/7/19 | NITE | Nightstar Therapeutics Plc | X0 | Health | BioPrd | Biological Products, (No Diag | Sundaram Senthil Vel | MA | O | CFO | S | -5 | 12.98 | 0 | 0 | 0 | 127 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |